Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
Saved in:
| Title: | Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience. |
|---|---|
| Authors: | Choucair K; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Page SJ; Cancer Center of Kansas, Wichita, KS., Mattar BI; Cancer Center of Kansas, Wichita, KS., Dakhil CS; Cancer Center of Kansas, Wichita, KS., Nabbout NH; Cancer Center of Kansas, Wichita, KS., Deutsch JM; Cancer Center of Kansas, Wichita, KS., Truong QV; Cancer Center of Kansas, Wichita, KS., Truong PV; Cancer Center of Kansas, Wichita, KS., Moore DF Jr; Cancer Center of Kansas, Wichita, KS., Cannon MW; Cancer Center of Kansas, Wichita, KS., Kallail KJ; Kansas University School of Medicine, Wichita, KS., Moore JA; Cancer Center of Kansas, Wichita, KS., Dakhil SR; Cancer Center of Kansas, Wichita, KS., Diab R; Kansas University School of Medicine, Wichita, KS., Kamran S; Kansas University School of Medicine, Wichita, KS., Reddy PS; Cancer Center of Kansas, Wichita, KS; Kansas University School of Medicine, Wichita, KS. Electronic address: pavansreddy@gmail.com. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2023 Feb; Vol. 23 (2), pp. 155-161. Date of Electronic Publication: 2022 Nov 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
